InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Vitt Daniel, Chief Executive Officer. Officer active across 1 companies, notably Immunic, INC.. Aggregated, 3 reports have been logged. Total volume traded: €31k. The latest transaction was disclosed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€14,4175,000 shares@ €2.88330.0088% mcap46.8% of flow
Common Stock
SEC:0001193805-22-000919:0·
Ideal exit: 28 Feb 2023 (T+270)
€8,1891,000 shares@ €8.1888100.0% of flow
Common Stock
SEC:0001193805-21-001161·
Ideal exit: 7 May 2022 (T+270)
€8,1891,000 shares@ €8.18880.0050% mcap26.6% of flow
Common Stock
SEC:0001193805-21-001161:0·
Ideal exit: 7 May 2022 (T+270)
3 of 3 declarations
About Vitt Daniel
Daniel Vitt is the President and CEO of Immunic, Inc. He leads the strategic and business operations of the company, focusing on innovation in the biotechnology sector. His leadership is essential in guiding the company's vision and growth.
